Evaluating Metabolic Health in People Aged 18 to 60 by Nutrilite Metabolic Health Index

NCT ID: NCT07161557

Last Updated: 2025-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-09

Study Completion Date

2026-05-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to evaluate Metabolic Health by fit analysis between calculated Nutrilite Metabolic Health Index and the result of Metabolomics analysis from blood plasma samples in healthy adult participants aged between 18 and 60 years. The main question it aims to answer:

\- Does the Nutrilite Metabolic Health Index fit well with the result of Metabolomics analysis from blood plasma samples?

200 eligible participants will be enrolled in a single center, one site visit will be made to finish a health questionnaire, a lifestyle questionnaire, a routine physical checkup. Blood samples will be collected for routine blood test (blood sugar, total triglycerides, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, uric acid), and for Metabolomics testing.

Researchers will calculate the Nutrilite Metabolic Health Index based on participant data, and do the fit analysis against the result from Metabolomics analysis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Abnormality Metabolic Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All participants

All participants enrolled will be asked to fill out the questionnaires, have physical checkup, and take blood samples, no interventions involved.

No Intervention: Observational Cohort

Intervention Type OTHER

No intervention involved, participants will fill out some questionnaires and blood samples will drawn for test and analysis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No Intervention: Observational Cohort

No intervention involved, participants will fill out some questionnaires and blood samples will drawn for test and analysis.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female volunteers, aged 18 to 60, regardless of gender;
* Not participating in other interventional clinical studies;
* Have a good understanding of the nature, purpose, benefits obtained, and possible risks and side effects of the study;
* Willing to comply with all trial requirements and procedures;
* Sign the informed consent form.

Exclusion Criteria

* In the treatment of gastrointestinal symptoms;
* Those who are lactose intolerant, allergic to fish and their products;
* Current suffering from other organic diseases affecting bowel function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, Hirschsprung's disease, scleroderma, anorexia nervosa, etc.;
* Diet control, exercise enhancement, or taking medications that control weight or affect appetite in the past 3 months;
* Volunteers have any of the following medical history or have been clinically diagnosed with the following diseases that may affect the evaluation of the test results: obvious gastrointestinal disorders, liver, kidney, endocrine, blood, respiratory and cardiovascular diseases;
* Current or past abuse of alcohol or other illicit drugs, supplements, or OTC prescriptions 3 / 11 Research content Collection of biological samples or information data Evaluation indicators Drugs may cause intestinal dysfunction or affect the evaluation of trial effects;
* Frequent use of drugs that may affect gastrointestinal function or immune system according to the investigator's judgment.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Amway (China) R&D Center

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zheng Qu

Role: PRINCIPAL_INVESTIGATOR

Shanghai MCC Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shanghai MCC Hospital

Shanghai, Shanghai Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Charlie Zhang, MD

Role: CONTACT

+8613901981272

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

24-RD-10-AY-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.